Skip to content
MedsAcross

Medicine

Carbamazepine 100 mg tablet

Available on requestPrescription onlyUS FDAGeneric name

Carbamazepine 100 mg tablet is a generic prescription medicine for oral use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20ºC to 25ºC (68ºF to 77ºF), excursions permitted between 15ºC to…

Key facts

Active ingredient (INN)
Carbamazepine
Brand
Sold under the generic name
Strength
100 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 1000 tablets and 1 more
Manufacturers
Umedica LaboratoriesIndiaNivagen Pharmaceuticals
Origin register
US FDA, United States
Storage
Store at 20ºC to 25ºC (68ºF to 77ºF), excursions permitted between 15ºC to 30ºC (59ºF to 86ºF). Protect from moisture.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
N03AF01 Carbamazepine
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
21 April 2020
Identifiers
RxCUI 197441, 308979DailyMed set ID f3465f71-8931-43b6-baea-eac7046a4400, e68998cb-5f91-4d7e-85a6-555efb8b0384NDC 60290-034, 75834-220Application ANDA207798

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 tablet in 1 bottle60290-034-02Umedica LaboratoriesIndia21 April 2020
1000 tablet in 1 bottle60290-034-03Umedica LaboratoriesIndia21 April 2020
1000 tablet in 1 bottle75834-220-00Nivagen Pharmaceuticals21 April 2020
100 tablet in 1 bottle75834-220-01Nivagen Pharmaceuticals21 April 2020

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 11 March 1968Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Carbamazepine

Clinical summary

Carbamazepine is a mood stabilizer indicated as an anticonvulsant drug. It is available as extended-release tablets, tablets and extended-release capsules for oral use. MedsAcross supplies Carbamazepine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Carbamazepine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Carbamazepine 100 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.